Royal Philips Electronics has taken an 80% stake in a joint venture with SHL TeleMedicine to develop new markets for cardiology telemedicine products and services across Europe. The goal is to establish medical call centers and remote
Royal Philips Electronics has taken an 80% stake in a joint venture with SHL TeleMedicine to develop new markets for cardiology telemedicine products and services across Europe. The goal is to establish medical call centers and remote monitoring services for people with cardiac disease. The venture is headquartered in the Netherlands and managed by a joint Philips/SHL team. SHL, an Israeli provider of personal telemedicine systems and call center services, has the option of increasing its stake to 35% in the future. The company claims more than 55,000 subscribers to its services in Israel and already oversees operations in the U.K., Portugal, and Croatia through similar joint-venture arrangements with other partners.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.